Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPC3-CART TAI in Advanced Hepatocellular Carcinoma
NCT02715362Phase 2Unknown
- Sponsor
- Shanghai Genechem
- Start
- Mar 2016
- Primary completion
- Jul 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of GPC3-CART cells in hepatocellular carcinoma (HCC), sponsored by Shanghai Genechem. Status: unknown.
02
Drugs
GPC3-CART cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02715362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715362.